{"id":919,"date":"2021-03-05T19:34:04","date_gmt":"2021-03-05T18:34:04","guid":{"rendered":"https:\/\/p2med.imibic.org\/?page_id=919"},"modified":"2023-10-02T11:11:55","modified_gmt":"2023-10-02T09:11:55","slug":"proscango","status":"publish","type":"page","link":"https:\/\/p2med.imibic.org\/?page_id=919","title":{"rendered":"ProsCanGO"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-1132 alignleft\" src=\"https:\/\/p2med.imibic.org\/wp-content\/uploads\/2021\/04\/Andre-redonda-1.png\" alt=\"\" width=\"163\" height=\"162\" \/><strong>Andr\u00e9 Morais Sarmento Borges Cabral<\/strong> (PhD) works in the group GC27 OncObesity and Metabolism, led by Dr. Ra\u00fal M. Luque Huertas (PI) and Dr. Manuel David Gahete Ortiz (Co-PI). His project is titled <strong>ProsCanGO \u2013 Role of GOAT\/Ghrelin system in the pathological interaction between obesity and prostate cancer: Identification of novel personalized diagnostic, prognostic and therapeutic targets. <\/strong>The expected results include the definition of the key molecular and endocrine-metabolic mechanisms linking GOAT\/ Ghrelin system with prostate cancer and obesity and generation of knowledge that will help with the design of new personalised diagnostic tests, predictive markers, and therapeutic targets for prostate cancer. The project will last for 3 years, from March 2021 till March 2024.<\/p>\n\t\t\t\t\t\t<style>\r\n\t\t\t\t#wpsm_accordion_1105 .wpsm_panel-heading{\r\n\tpadding:0px !important;\r\n}\r\n#wpsm_accordion_1105 .wpsm_panel-title {\r\n\tmargin:0px !important; \r\n\ttext-transform:none !important;\r\n\tline-height: 1 !important;\r\n}\r\n#wpsm_accordion_1105 .wpsm_panel-title a{\r\n\ttext-decoration:none;\r\n\toverflow:hidden;\r\n\tdisplay:block;\r\n\tpadding:0px;\r\n\tfont-size: 16px !important;\r\n\tfont-family: Arial !important;\r\n\tcolor:#000000 !important;\r\n\tborder-bottom:0px !important;\r\n}\r\n\r\n#wpsm_accordion_1105 .wpsm_panel-title a:focus {\r\noutline: 0px !important;\r\n}\r\n\r\n#wpsm_accordion_1105 .wpsm_panel-title a:hover, #wpsm_accordion_1105 .wpsm_panel-title a:focus {\r\n\tcolor:#000000 !important;\r\n}\r\n#wpsm_accordion_1105 .acc-a{\r\n\tcolor: #000000 !important;\r\n\tbackground-color:#3876ba !important;\r\n\tborder-color: #ddd;\r\n}\r\n#wpsm_accordion_1105 .wpsm_panel-default > .wpsm_panel-heading{\r\n\tcolor: #000000 !important;\r\n\tbackground-color: #3876ba !important;\r\n\tborder-color: #3876ba !important;\r\n\tborder-top-left-radius: 0px;\r\n\tborder-top-right-radius: 0px;\r\n}\r\n#wpsm_accordion_1105 .wpsm_panel-default {\r\n\t\tborder:1px solid transparent !important;\r\n\t}\r\n#wpsm_accordion_1105 {\r\n\tmargin-bottom: 20px;\r\n\toverflow: hidden;\r\n\tfloat: none;\r\n\twidth: 100%;\r\n\tdisplay: block;\r\n}\r\n#wpsm_accordion_1105 .ac_title_class{\r\n\tdisplay: block;\r\n\tpadding-top: 12px;\r\n\tpadding-bottom: 12px;\r\n\tpadding-left: 15px;\r\n\tpadding-right: 15px;\r\n}\r\n#wpsm_accordion_1105  .wpsm_panel {\r\n\toverflow:hidden;\r\n\t-webkit-box-shadow: 0 0px 0px rgba(0, 0, 0, .05);\r\n\tbox-shadow: 0 0px 0px rgba(0, 0, 0, .05);\r\n\t\tborder-radius: 4px;\r\n\t}\r\n#wpsm_accordion_1105  .wpsm_panel + .wpsm_panel {\r\n\t\tmargin-top: 5px;\r\n\t}\r\n#wpsm_accordion_1105  .wpsm_panel-body{\r\n\tbackground-color:#f8f8f8 !important;\r\n\tcolor:#000000 !important;\r\n\tborder-top-color: #3876ba !important;\r\n\tfont-size:14px !important;\r\n\tfont-family: Arial !important;\r\n\toverflow: hidden;\r\n\t\tborder: 2px solid transparent !important;\r\n\t}\r\n\r\n#wpsm_accordion_1105 .ac_open_cl_icon{\r\n\tbackground-color:#3876ba !important;\r\n\tcolor: #000000 !important;\r\n\tfloat:right !important;\r\n\tpadding-top: 12px !important;\r\n\tpadding-bottom: 12px !important;\r\n\tline-height: 1.0 !important;\r\n\tpadding-left: 15px !important;\r\n\tpadding-right: 15px !important;\r\n\tdisplay: inline-block !important;\r\n}\r\n\r\n\t\t\t\r\n\t\t\t\t\r\n\t\r\n\t\t\t<\/style>\r\n\t\t\t<div class=\"wpsm_panel-group\" id=\"wpsm_accordion_1105\" >\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t<!-- Inner panel Start -->\r\n\t\t\t\t\t<div class=\"wpsm_panel wpsm_panel-default\">\r\n\t\t\t\t\t\t<div class=\"wpsm_panel-heading\" role=\"tab\" >\r\n\t\t\t\t\t\t  <h4 class=\"wpsm_panel-title\">\r\n\t\t\t\t\t\t\t<a  class=\"\"  data-toggle=\"collapse\" data-parent=\"\" href=\"javascript:void(0)\" data-target=\"#ac_1105_collapse1\"  >\r\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"ac_open_cl_icon fa fa-plus\"><\/span>\r\n\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t \r\n\t\t\t\t\t\t\t\t<span class=\"ac_title_class\">\r\n\t\t\t\t\t\t\t\t\tAbstract\t\t\t\t\t\t\t\t<\/span>\r\n\t\t\t\t\t\t\t<\/a>\r\n\t\t\t\t\t\t  <\/h4>\r\n\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t<div id=\"ac_1105_collapse1\" class=\"wpsm_panel-collapse collapse \"  >\r\n\t\t\t\t\t\t  <div class=\"wpsm_panel-body\">\r\n\t\t\t\t\t\t\t<p>Prostate cancer (PCa) is a major health threat, the most common malignancy in men and a leading cause of cancer-related death. Unfortunately, early detection and clinical management of PCa face severe limitations. Lack of specific diagnostic\/prognostic markers causes under-diagnosis and overtreatment, and patients are often unresponsive or develop resistance to existing therapies. <\/p>\r\n\r\n<p>This project aims to develop a novel approach to improve personalized PCa management, using the endocrine-metabolic ghrelin system. Two components of this system, Ghrelin O-Acyl Transferase (GOAT) enzyme and In1-ghrelin (In1) variant were shown to be overexpressed in and secreted from PCa by the host group. In their pilot tests, GOAT\/In1 plasma\/urine levels can distinguish between PCa and healthy subjects, especially when stratified by obesity, a relevant risk factor for PCa. <\/p>\r\n\r\n<p>Here, it is proposed to deploy a comprehensive and innovative analysis of the pathological role of GOAT\/In1 in PCa as a tool to identify novel integrative and tailored PCa biomarker fingerprints, enabling the development of better diagnosis\/prognosis tools and therapeutic targets to combat PCa. To this end, a transdisciplinary, integrated project is proposed to: 1) collect and analyze samples (normal\/PCa tissue, blood, urine) from retrospective (n=1070) and prospective (n=350) cohorts of early and advanced PCa patients; 2) identify novel markers through cutting-edge approaches (microfluidic-based qPCR quantifying 96 transcripts in 96 samples simultaneously); 3) interrogate the role of selected molecules in preclinical models; 4) use cell systems to mechanistically clarify molecular questions. <\/p>\r\n\r\n<p>Finally, the information obtained will be integrated and bioinformatically modeled to define the key molecular and endocrine-metabolic mechanisms linking GOAT\/In1 system with PCa and obesity, and, most importantly, to design new personalized diagnostic tests and define predictive markers and therapeutic targets for PCa patients.<\/p>\t\t\t\t\t\t  <\/div>\r\n\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t<\/div>\r\n\t\t\t\t\t<!-- Inner panel End -->\r\n\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t<!-- Inner panel Start -->\r\n\t\t\t\t\t<div class=\"wpsm_panel wpsm_panel-default\">\r\n\t\t\t\t\t\t<div class=\"wpsm_panel-heading\" role=\"tab\" >\r\n\t\t\t\t\t\t  <h4 class=\"wpsm_panel-title\">\r\n\t\t\t\t\t\t\t<a  class=\"collapsed\"  data-toggle=\"collapse\" data-parent=\"\" href=\"javascript:void(0)\" data-target=\"#ac_1105_collapse2\"  >\r\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"ac_open_cl_icon fa fa-plus\"><\/span>\r\n\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t \r\n\t\t\t\t\t\t\t\t<span class=\"ac_title_class\">\r\n\t\t\t\t\t\t\t\t\tObjectives\t\t\t\t\t\t\t\t<\/span>\r\n\t\t\t\t\t\t\t<\/a>\r\n\t\t\t\t\t\t  <\/h4>\r\n\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t\t<div id=\"ac_1105_collapse2\" class=\"wpsm_panel-collapse collapse \"  >\r\n\t\t\t\t\t\t  <div class=\"wpsm_panel-body\">\r\n\t\t\t\t\t\t\t<p>The main objective of ProsCanGO is to develop a radically innovative approach to improve personalised Prostate Cancer (PCa) diagnosis by defining new integrative diagnosis biomarkers with prognostic and predictive capabilities. The global aim is to valorize the utility of GOAT\/In1-ghrelin (In1) for the early PCa detection, define their roles in PCa pathogenesis and expoite their potential predictive\/therapeutic utility. The project is structure into three distictive but interrelated specific objectives, excecuted in an interactive manner by deploying an ample repertoire of multidisciplinary state-of-the-art analyses on samples obtained from multicenter human clinical studies and innovative animal\/cellular models.<\/p>\r\n\r\n<p><strong>Objective 1<\/strong>: To valorize the role of GOAT\/In1 and to identify novel, complementary biomarkers to be used as non-invasive diagnostic fingerprint of PCa.<\/p>\r\n\r\n<p><strong>Objective 2<\/strong>: To define the potential of GOAT\/In1 and associated factors identified in Objective 1 as clinical predictors of progression, aggressiveness and response to treatment of PCa.<\/p>\r\n\r\n<p><strong>Objective 3<\/strong>: To explore the regulation, oncogenic role, mechanism of action and potential therapeutic utility of PCa of GOAT\/In1 and associated components identified in objectives 1 and 2. To identify the regulatory mechanism of these elements, exploring putative genomic SNPs\/methylation patterns expression in PCa cells.<\/p>\t\t\t\t\t\t  <\/div>\r\n\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t<\/div>\r\n\t\t\t\t\t<!-- Inner panel End -->\r\n\t\t\t\t\t\r\n\t\t\t\t\t\t\t<\/div>\r\n\t\t\t\n<h4>Dissemination activities<\/h4>\n<p>&nbsp;<\/p>\n<p><em><strong>European Researchers&#8217; Night 2023<\/strong><\/em><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-1704\" src=\"https:\/\/p2med.imibic.org\/wp-content\/uploads\/2023\/10\/Noche-2023.jpg\" alt=\"\" width=\"1653\" height=\"869\" srcset=\"https:\/\/p2med.imibic.org\/wp-content\/uploads\/2023\/10\/Noche-2023.jpg 1653w, https:\/\/p2med.imibic.org\/wp-content\/uploads\/2023\/10\/Noche-2023-300x158.jpg 300w, https:\/\/p2med.imibic.org\/wp-content\/uploads\/2023\/10\/Noche-2023-1024x538.jpg 1024w, https:\/\/p2med.imibic.org\/wp-content\/uploads\/2023\/10\/Noche-2023-768x404.jpg 768w, https:\/\/p2med.imibic.org\/wp-content\/uploads\/2023\/10\/Noche-2023-1536x807.jpg 1536w\" sizes=\"auto, (max-width: 1653px) 100vw, 1653px\" \/><\/p>\n<p>This year <a href=\"https:\/\/lanochedelosinvestigadores.fundaciondescubre.es\/investigador\/andre-morais-sarmento-borges-cabral\/\">Andr\u00e9<\/a> has doubled his participation in this popular activity with the general public He participated on 27 September in a very interesting meeting at the internationally renowned <a href=\"https:\/\/patios.cordoba.es\/\"><em>Patios de C\u00f3rdoba<\/em><\/a> to debate with 15 participants<img loading=\"lazy\" decoding=\"async\" class=\"wp-image-1706 alignleft\" src=\"https:\/\/p2med.imibic.org\/wp-content\/uploads\/2023\/10\/andre-e1696236129319.jpg\" alt=\"\" width=\"153\" height=\"164\" srcset=\"https:\/\/p2med.imibic.org\/wp-content\/uploads\/2023\/10\/andre-e1696236129319.jpg 1682w, https:\/\/p2med.imibic.org\/wp-content\/uploads\/2023\/10\/andre-e1696236129319-280x300.jpg 280w, https:\/\/p2med.imibic.org\/wp-content\/uploads\/2023\/10\/andre-e1696236129319-956x1024.jpg 956w, https:\/\/p2med.imibic.org\/wp-content\/uploads\/2023\/10\/andre-e1696236129319-768x823.jpg 768w, https:\/\/p2med.imibic.org\/wp-content\/uploads\/2023\/10\/andre-e1696236129319-1434x1536.jpg 1434w\" sizes=\"auto, (max-width: 153px) 100vw, 153px\" \/> about &#8220;<a href=\"https:\/\/lanochedelosinvestigadores.fundaciondescubre.es\/actividades\/una-sociedad-mas-sana-es-posible-la-investigacion-biomedica-frente-al-cancer-y-la-obesidad\/\">A healthier society is possible: biomedical research to fight cancer and obesity<\/a>&#8220;. They talked about new strategies to face up this epidemy of the XXI century, and of new research lines, new therapy targets, the use of virus that infect and destroy tumours, as well as the role of hormonal changes in the onset of metabolic diseases like obesity, diabetes and some types of cancer.<\/p>\n<p>Later on 29 September he was also part of the <img loading=\"lazy\" decoding=\"async\" class=\" wp-image-1707 alignright\" src=\"https:\/\/p2med.imibic.org\/wp-content\/uploads\/2023\/10\/cell.jpg\" alt=\"\" width=\"266\" height=\"127\" srcset=\"https:\/\/p2med.imibic.org\/wp-content\/uploads\/2023\/10\/cell.jpg 1657w, https:\/\/p2med.imibic.org\/wp-content\/uploads\/2023\/10\/cell-300x143.jpg 300w, https:\/\/p2med.imibic.org\/wp-content\/uploads\/2023\/10\/cell-1024x489.jpg 1024w, https:\/\/p2med.imibic.org\/wp-content\/uploads\/2023\/10\/cell-768x367.jpg 768w, https:\/\/p2med.imibic.org\/wp-content\/uploads\/2023\/10\/cell-1536x734.jpg 1536w\" sizes=\"auto, (max-width: 266px) 100vw, 266px\" \/><span style=\"font-size: 14px;\">large team that took on explaining about cells in the open event &#8220;<\/span><a style=\"font-size: 14px;\" href=\"https:\/\/lanochedelosinvestigadores.fundaciondescubre.es\/actividades\/aprendiendo-de-la-celula\/\">Learning from the cell<\/a><span style=\"font-size: 14px;\">&#8220;, which was organised at the main University building. They used day-to-day lab material and microscopes to show the public about tissue structure, cells cultures and basic biochemical experiments.\u00a0<\/span><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/p2med.imibic.org\/wp-content\/uploads\/2019\/06\/barra-violeta.png\" \/><\/p>\n<p><em><strong>European Researchers&#8217; Night 2022<\/strong><\/em><\/p>\n<p><a href=\"https:\/\/lanochedelosinvestigadores.fundaciondescubre.es\/actividades\/al-laboratorio\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\" wp-image-1589 alignleft\" src=\"https:\/\/p2med.imibic.org\/wp-content\/uploads\/2022\/09\/Taller-ninos-2022-Andre.png\" alt=\"\" width=\"267\" height=\"242\" srcset=\"https:\/\/p2med.imibic.org\/wp-content\/uploads\/2022\/09\/Taller-ninos-2022-Andre.png 611w, https:\/\/p2med.imibic.org\/wp-content\/uploads\/2022\/09\/Taller-ninos-2022-Andre-300x272.png 300w\" sizes=\"auto, (max-width: 267px) 100vw, 267px\" \/><\/a><\/p>\n<p>In this workshop on the 30th of September at 7pm, <a href=\"https:\/\/lanochedelosinvestigadores.fundaciondescubre.es\/investigador\/andre-morais-sarmento-borges-cabral\/\" target=\"_blank\" rel=\"noopener\">Andr\u00e9<\/a> and other researchers will teach kids about the materials that are normally used in a laboratory, such as pipettes, optical microscopes and cell culture materials. Children will get a chance to perform biomedical experiments and learn about the structure of DNA.<\/p>\n<p>More information <a href=\"https:\/\/lanochedelosinvestigadores.fundaciondescubre.es\/actividades\/al-laboratorio\/\" target=\"_blank\" rel=\"noopener\">here<\/a>.<\/p>\n<p>&nbsp;<\/p>\n<p><img decoding=\"async\" src=\"https:\/\/p2med.imibic.org\/wp-content\/uploads\/2019\/06\/barra-violeta.png\" \/><\/p>\n<p>Andr\u00e9 was invited to talk about his study of new biomarkers for diagnostics of prostate cancer in the programme &#8220;Researchers around the world&#8221;.<\/p>\n<p>Listen to the interview [in spanish] <a href=\"https:\/\/www.ivoox.com\/busqueda-biomarcadores-para-diagnostico-cancer-audios-mp3_rf_76453230_1.html\" target=\"_blank\" rel=\"noopener\">here!<\/a><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-1451\" src=\"https:\/\/p2med.imibic.org\/wp-content\/uploads\/2022\/02\/Andre_radio_interview.png\" alt=\"\" width=\"594\" height=\"350\" srcset=\"https:\/\/p2med.imibic.org\/wp-content\/uploads\/2022\/02\/Andre_radio_interview.png 594w, https:\/\/p2med.imibic.org\/wp-content\/uploads\/2022\/02\/Andre_radio_interview-300x177.png 300w\" sizes=\"auto, (max-width: 594px) 100vw, 594px\" \/><\/p>\n<p>&nbsp;<\/p>\n<p><img decoding=\"async\" src=\"https:\/\/p2med.imibic.org\/wp-content\/uploads\/2019\/06\/barra-violeta.png\" \/><\/p>\n<h4>Open Access publications<\/h4>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/zenodo.org\/record\/6505114#.YoTCvahBz0s\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-1488 alignleft\" src=\"https:\/\/p2med.imibic.org\/wp-content\/uploads\/2022\/05\/In1-Ghrelin_Article_A-Cabral-1024x775.png\" alt=\"\" width=\"192\" height=\"146\" srcset=\"https:\/\/p2med.imibic.org\/wp-content\/uploads\/2022\/05\/In1-Ghrelin_Article_A-Cabral-1024x775.png 1024w, https:\/\/p2med.imibic.org\/wp-content\/uploads\/2022\/05\/In1-Ghrelin_Article_A-Cabral-300x227.png 300w, https:\/\/p2med.imibic.org\/wp-content\/uploads\/2022\/05\/In1-Ghrelin_Article_A-Cabral-768x581.png 768w, https:\/\/p2med.imibic.org\/wp-content\/uploads\/2022\/05\/In1-Ghrelin_Article_A-Cabral.png 1184w\" sizes=\"auto, (max-width: 192px) 100vw, 192px\" \/><\/a><a href=\"https:\/\/zenodo.org\/record\/6505114#.YoTCvahBz0s\" target=\"_blank\" rel=\"noopener\">In1-Ghrelin Splicing Variant as a Key Element in the Pathophysiological Association Between Obesity and Prostate Cancer.<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2162253122000385?via%3Dihub\" target=\"_blank\" rel=\"noopener\">Dysregulation of the miRNome unveils a <img loading=\"lazy\" decoding=\"async\" class=\"wp-image-1486 alignleft\" src=\"https:\/\/p2med.imibic.org\/wp-content\/uploads\/2022\/05\/Dysregulation_Article_A-Cabral_2.png\" alt=\"\" width=\"190\" height=\"153\" srcset=\"https:\/\/p2med.imibic.org\/wp-content\/uploads\/2022\/05\/Dysregulation_Article_A-Cabral_2.png 912w, https:\/\/p2med.imibic.org\/wp-content\/uploads\/2022\/05\/Dysregulation_Article_A-Cabral_2-300x242.png 300w, https:\/\/p2med.imibic.org\/wp-content\/uploads\/2022\/05\/Dysregulation_Article_A-Cabral_2-768x620.png 768w\" sizes=\"auto, (max-width: 190px) 100vw, 190px\" \/>crosstalk between obesity and prostate cancer: miR-107 as a personalized diagnostic and therapeutic tool.<\/a><img decoding=\"async\" src=\"https:\/\/p2med.imibic.org\/wp-content\/uploads\/2019\/06\/barra-violeta.png\" \/><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-1515\" src=\"https:\/\/p2med.imibic.org\/wp-content\/uploads\/2022\/06\/seminar-andre.png\" alt=\"\" width=\"946\" height=\"712\" srcset=\"https:\/\/p2med.imibic.org\/wp-content\/uploads\/2022\/06\/seminar-andre.png 946w, https:\/\/p2med.imibic.org\/wp-content\/uploads\/2022\/06\/seminar-andre-300x226.png 300w, https:\/\/p2med.imibic.org\/wp-content\/uploads\/2022\/06\/seminar-andre-768x578.png 768w\" sizes=\"auto, (max-width: 946px) 100vw, 946px\" \/><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-large wp-image-1538\" src=\"https:\/\/p2med.imibic.org\/wp-content\/uploads\/2022\/06\/UCOBioR-SEminar-Andre-1024x459.jpg\" alt=\"\" width=\"700\" height=\"314\" srcset=\"https:\/\/p2med.imibic.org\/wp-content\/uploads\/2022\/06\/UCOBioR-SEminar-Andre-1024x459.jpg 1024w, https:\/\/p2med.imibic.org\/wp-content\/uploads\/2022\/06\/UCOBioR-SEminar-Andre-300x135.jpg 300w, https:\/\/p2med.imibic.org\/wp-content\/uploads\/2022\/06\/UCOBioR-SEminar-Andre-768x344.jpg 768w, https:\/\/p2med.imibic.org\/wp-content\/uploads\/2022\/06\/UCOBioR-SEminar-Andre-1536x689.jpg 1536w, https:\/\/p2med.imibic.org\/wp-content\/uploads\/2022\/06\/UCOBioR-SEminar-Andre-670x300.jpg 670w, https:\/\/p2med.imibic.org\/wp-content\/uploads\/2022\/06\/UCOBioR-SEminar-Andre.jpg 1597w\" sizes=\"auto, (max-width: 700px) 100vw, 700px\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/p2med.imibic.org\/wp-content\/uploads\/2019\/06\/barra-violeta.png\" \/><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Andr\u00e9 Morais Sarmento Borges Cabral (PhD) works in the group GC27 OncObesity and Metabolism, led by Dr. Ra\u00fal M. Luque Huertas (PI) and Dr. Manuel David Gahete Ortiz (Co-PI). His project is titled ProsCanGO \u2013 Role of GOAT\/Ghrelin system in&hellip; <\/p>\n","protected":false},"author":2,"featured_media":1704,"parent":931,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_mi_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-919","page","type-page","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/p2med.imibic.org\/index.php?rest_route=\/wp\/v2\/pages\/919","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/p2med.imibic.org\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/p2med.imibic.org\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/p2med.imibic.org\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/p2med.imibic.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=919"}],"version-history":[{"count":24,"href":"https:\/\/p2med.imibic.org\/index.php?rest_route=\/wp\/v2\/pages\/919\/revisions"}],"predecessor-version":[{"id":1708,"href":"https:\/\/p2med.imibic.org\/index.php?rest_route=\/wp\/v2\/pages\/919\/revisions\/1708"}],"up":[{"embeddable":true,"href":"https:\/\/p2med.imibic.org\/index.php?rest_route=\/wp\/v2\/pages\/931"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/p2med.imibic.org\/index.php?rest_route=\/wp\/v2\/media\/1704"}],"wp:attachment":[{"href":"https:\/\/p2med.imibic.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=919"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}